SYDNEY, May 02, 2025 ( GLOBE NEWSWIRE ) -- IREN Limited IREN ( together with its subsidiaries, "IREN" ) today announced that it will release its financial results for the three and nine-months ended March 31, 2025, on Wednesday, May 14, 2025 and host a conference call beginning at 5:00 p.m.

Trade negotiation optimism, Apple and Amazon struggle, employment data due, and more...

Elon Musk, has expressed mixed feelings about his first 100 days in office, acknowledging progress in Department of Government Efficiency ( DOGE ) , but admitting limitations.

Crypto exchange KuCoin said that it may reenter South Korea after its platform was blocked in the country. On March 21, South Korean regulators ordered Google Play to block access to exchanges that were not compliant with the requirements needed to operate in the country.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Telsey Advisory Group cut Kohl's Corporation KSS price target from $10 to $9.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Telsey Advisory Group cut Kohl's Corporation KSS price target from $10 to $9.

ALK ( ALKB.DC / OMX: ALK B ) today announced a 4-year agreement with US-based ARS Pharmaceuticals, Inc. ( "ARS Pharma", NASDAQ: SPRY ) to co-promote the neffy® adrenaline ( epinephrine ) nasal spray to up to 9,000 named paediatricians in the USA. These paediatricians currently account for close ...

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 02, 2025 ( GLOBE NEWSWIRE ) -- ProQR Therapeutics NV. ( Nasdaq: PRQR ) ( ProQR ) , a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform today announced that Company ...

DALLAS, May 02, 2025 ( GLOBE NEWSWIRE ) -- Taysha Gene Therapies, Inc. ( Nasdaq: TSHA ) ( Taysha or the Company ) , a clinical-stage biotechnology company focused on advancing adeno-associated virus ( AAV ) -based gene therapies for severe monogenic diseases of the central nervous system ( CNS ) ...

ROCKAWAY, N.J., May 02, 2025 ( GLOBE NEWSWIRE ) -- electroCore, Inc. ( "ECOR," "electroCore," or the "Company" ) ECOR, a commercial-stage bioelectronic technology company, announced today the completion of the merger ( the "Merger" ) with NeuroMetrix, Inc. ( "NeuroMetrix" or "NURO" ) NURO, ...